BioCentury
ARTICLE | Company News

BioAlliance, Par Pharmaceutical sales and marketing update

September 6, 2010 7:00 AM UTC

Par's Strativa Pharmaceuticals unit launched Oravig miconazole in the U.S. to treat oropharyngeal candidiasis. Par has exclusive rights to market the extended-release bioadhesive antifungal buccal ta...